Scheduled presentations:

• The role of clinical and genomic characteristics in lung tumor dynamics
  *N. Dimitriou (Memorial Sloan Kettering Cancer Center), J. Willmann (University Hospital Zurich), E. Dee (Memorial Sloan Kettering Cancer Center), K. Pichotta (Memorial Sloan Kettering Cancer Center), W. Fu (Memorial Sloan Kettering Cancer Center), S. Salehi (Memorial Sloan Kettering Cancer Center), K. Boehm (Memorial Sloan Kettering Cancer Center), L. Schwartz (Memorial Sloan Kettering Cancer Center), P. Iyengar (Memorial Sloan Kettering Cancer Center), F. Sanchez-Vega (Memorial Sloan Kettering Cancer Center), S. Shah (Memorial Sloan Kettering Cancer Center), N. Schultz (Memorial Sloan Kettering Cancer Center), J. Carrot-Zhang (Memorial Sloan Kettering Cancer Center)
• Stochastic Dynamics of Prostate Cancer under Phytocannabinoid Therapy
  *M. Cerasuolo (University of Sussex), M. Jensen (UCL), A. Ligresti (IBC), R. Ronca (University of Brescia)
• Qualitative Optimization of Oncolytic Virotherapy and Immune Therapy Combination Treatments
  *T. Hillen (University of Alberta), N. Mohammadnejad (University of Alberta)
• Starving Tumours through Intermittent Fasting: Metabolic Allee Effect Leads to Growth Control
  *J. Jiménez-Sánchez (MOLAB, UCLM), A. Méndiz-Fernández (MOLAB, UCLM), B. Ocaña-Tienda (CNIO), J. Pérez-Beteta (MOLAB, UCLM), A. Erolés-Simó (I3M, UPV), E. Arana (IVO), P. Maini (Mathematical Institute, Oxford University), G. Fernández-Calvo (MOLAB, UCLM), V. Pérez-García (MOLAB, UCLM)
• Impacts of Genetic and Phenotypic Heterogeneity on Tumor Evolution and Therapy Response
  *S. Syga (TUD Dresden University of Technology), J. Nava-Sedeno (Universidad Nacional Autonoma de Mexico), A. Deutsch (TUD Dresden University of Technology)
• Age-Structured Modelling of Therapy-Induced Damage in Cancer Cell Populations
  *P. Guerrero (Universidad Carlos III de Madrid)